BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6131079)

  • 1. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
    Skamene A; Patel YC
    Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin-28 does not regulate islet function in the dog.
    Klaff LJ; Dunning BE; Taborsky GJ
    Endocrinology; 1988 Dec; 123(6):2668-74. PubMed ID: 2904358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma free fatty acid levels contribute to the hypersomatostatinemia of insulin deficiency.
    Wasada T; Howard B; McCorkle K; Harris V; Unger RH
    Diabetes; 1981 Apr; 30(4):358-61. PubMed ID: 6110603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in somatostatin and other islet cell functions in the spontaneously diabetic BB Wistar rat: biochemical and morphological characterization.
    Patel YC; Ruggere D; Malaisse-Lagae F; Orci L
    Metabolism; 1983 Jul; 32(7 Suppl 1):18-25. PubMed ID: 6135136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in somatostatin to glucagon ratio in islets of alloxan-diabetic dogs: effect of insulin-induced euglycemia.
    Rastogi KS; Brubaker PL; Kawasaki A; Efendic S; Vranic M
    Can J Physiol Pharmacol; 1993 Jul; 71(7):512-7. PubMed ID: 7902197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acetylcholine on the release of pancreatic and gastric somatostatin-like immunoreactivity in normal, chemically sympathectomized and indomethacin-treated dogs.
    Schusdziarra V; Stapelfeldt W; Klier M; Pfeiffer EF
    Hepatogastroenterology; 1982 Aug; 29(4):153-6. PubMed ID: 6127302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersecretion of gastric somatostatin in spontaneously diabetic BB rats.
    Ruggere MD; Patel YC
    Diabetes; 1987 Jul; 36(7):849-52. PubMed ID: 2884158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.
    Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH
    Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.